Eurofins Scientific SE (EPA:ERF)

Market Cap	10.42B
Revenue (ttm)	7.14B
Net Income (ttm)	380.90M
Shares Out	177.18M
EPS (ttm)	1.98
PE Ratio	29.64
Forward PE	14.55
Dividend	0.60 (1.02%)
Ex-Dividend Date	Apr 28, 2025

Volume	253,533
Average Volume	237,410
Open	59.04
Previous Close	59.04
Day's Range	58.74 - 59.26
52-Week Range	45.56 - 69.40
Beta	0.88
RSI	46.15
Earnings Date	Mar 1, 2026

About Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, training, advisory, and labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include susta...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1987
• Employees: 62,696
• Stock Exchange: Euronext Paris
• Ticker Symbol: ERF

Financial Performance

In 2024, Eurofins Scientific SE's revenue was 6.95 billion, an increase of 6.70% compared to the previous year's 6.51 billion. Earnings were 356.30 million, an increase of 38.91%.